PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
3.16%
Revenue growth above 1.5x ADI's 1.17%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
7.64%
Positive gross profit growth while ADI is negative. John Neff would see a clear operational edge over the competitor.
-97.12%
Negative EBIT growth while ADI is at 12.77%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-97.12%
Negative operating income growth while ADI is at 12.77%. Joel Greenblatt would press for urgent turnaround measures.
0.75%
Net income growth under 50% of ADI's 8.51%. Michael Burry would suspect the firm is falling well behind a key competitor.
-7.69%
Negative EPS growth while ADI is at 8.70%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
No Data
No Data available this quarter, please select a different quarter.
26.80%
Share change of 26.80% while ADI is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
-7.31%
Reduced diluted shares while ADI is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-21.13%
Dividend reduction while ADI stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
19.36%
Positive OCF growth while ADI is negative. John Neff would see this as a clear operational advantage vs. the competitor.
62.50%
Positive FCF growth while ADI is negative. John Neff would see a strong competitive edge in net cash generation.
77.23%
10Y revenue/share CAGR at 75-90% of ADI's 91.39%. Bill Ackman would press for new markets or product lines to narrow the gap.
35.62%
5Y revenue/share CAGR at 75-90% of ADI's 42.56%. Bill Ackman would encourage strategies to match competitor’s pace.
28.40%
3Y revenue/share CAGR 1.25-1.5x ADI's 24.73%. Bruce Berkowitz might see better product or regional expansions than the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
627.81%
3Y OCF/share CAGR above 1.5x ADI's 354.07%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
954.25%
10Y net income/share CAGR of 954.25% while ADI is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
40.07%
Net income/share CAGR of 40.07% while ADI is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
314.28%
3Y net income/share CAGR 1.25-1.5x ADI's 279.06%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-6.17%
Negative 3Y equity/share growth while ADI is at 19.30%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
3.56%
Dividend/share CAGR of 3.56% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
-41.28%
Negative near-term dividend growth while ADI invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
10.84%
AR growth well above ADI's 3.64%. Michael Burry fears inflated revenue or higher default risk in the near future.
2.55%
We show growth while ADI is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
7.36%
Asset growth above 1.5x ADI's 1.19%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-15.41%
We have a declining book value while ADI shows 4.03%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
1.99%
Debt growth far above ADI's 1.46%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
8.63%
We expand SG&A while ADI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.